Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Launch of a phase 3 clinical trial in the treatment of Alzheimer’s disease with masitinib
Effect of Multiple Sclerosis Disease-Modifying Therapies on B Cells and Humoral Immunity.
Advances in T Helper 17 Cell Biology: Pathogenic Role and Potential Therapy in Multiple Sclerosis.
Acute disseminated encephalomyelitis and dengue fever: Comment.
Diffusion abnormality in Balo's concentric sclerosis: clues for the pathogenesis.
Anatomical and functional aspects of mu opioid receptors in epileptic WAG/Rij rats.
Origin of oligodendrocytes in mammalian forebrains: a revised perspective.
Molecular and genetic requirements for preferential recruitment of TCRBV8S2+ T cells in Lewis rat experimental autoimmune encephalomyelitis.
Enhanced mirror activity in 'crossed' reaction time tasks in multiple sclerosis.
Niacin-mediated Tace activation ameliorates CMT neuropathies with focal hypermyelination.
N'-(arylsulfonyl)pyrazoline-1-carboxamidines as novel, neutral 5-hydroxytryptamine 6 receptor (5-HT₆R) antagonists with unique structural features.
Anti-Inflammatory and Antioxidant Mechanism of Tangeretin in Activated Microglia.
Restrained Th17 response and myeloid cell infiltration into the central nervous system by human decidua-derived mesenchymal stem cells during experimental autoimmune encephalomyelitis.
Treatment Effects for Dysphagia in Adults with Multiple Sclerosis: A Systematic Review.
Proton MR spectroscopy with metabolite-nulling reveals elevated macromolecules in acute multiple sclerosis.
Attentional performance of (C57BL/6Jx129Sv)F2 mice in the five-choice serial reaction time task.
Disease onset in familial and sporadic multiple sclerosis in Argentina.
Ultrasonic Elastography Evaluation in Optic Neuritis.
Corpus callosum thickness in children: an MR pattern-recognition approach on the midsagittal image.
Methylprednisolone increases neuronal apoptosis during autoimmune CNS inflammation by inhibition of an endogenous neuroprotective pathway.
Phase IV, Rater-blinded, Randomized Study, Comparing the Effects of 250 mg of Betaseron With 20 mg of Copaxone in Patients With the Relapsing-remitting or Clinically Isolated Forms of Multiple Sclerosis Using 3 Tesla MRI With Triple-dose Gadolinium
A case-control study of risk factors for multiple sclerosis in Iran.
CNS demyelination and enhanced myelin-reactive responses after ipilimumab treatment.
Clinical Overlap of Multiple Sclerosis and Autoimmune Hepatitis: Three Cases.
Characteristics of Patients With Relapsing Remitting Multiple Sclerosis Taking Once Daily Fingolimod Capsules In The United States.
Pages
« first
‹ previous
…
726
727
728
729
730
731
732
733
734
…
next ›
last »